Literature DB >> 18199516

Sensitivity of intensity modulated proton therapy plans to changes in patient weight.

Francesca Albertini1, Alessandra Bolsi, Antony J Lomax, Hans Peter Rutz, Beate Timmerman, Gudrun Goitein.   

Abstract

PURPOSE: A retrospective study to investigate the sensitivity of intensity modulated proton therapy (IMPT) to changes in body weight occurring during the course of radiotherapy for patients treated in the sacral region.
MATERIALS AND METHODS: During therapy, important weight gain and loss were observed for two patients treated to para-spinal tumors, which resulted in both patients being re-scanned and re-planned. Both patients were treated as part of their therapy, with a narrow-angle IMPT (NA-IMPT) plan delivering a 'dose hole' around the cauda equina (CE), which was mainly formed through modulation of Bragg peaks in depth. To investigate the impact of these weight changes on the proton range and delivered dose, the nominal fields were re-calculated on the new CT data sets. Results were analyzed by comparing these new plans with those originally delivered and by calculating changes in range and delivered doses in target volumes and normal tissues.
RESULTS: Maximum differences in proton range in the CE region of up to +8 mm and -13 mm, respectively, for the patient who gained weight and for the patient who lost weight, increased the maximum dose to the CE by only 2%. This indicates that both IMPT plans were relatively insensitive to substantial range uncertainties. Even greater differences in range (16 mm) in the planning target volume only slightly affected its dose homogeneity (differences in V(90%) of 6% in the worst case). Nevertheless, some large undesired local dose differences were observed.
CONCLUSIONS: We demonstrated, that, at least for the two analyzed cases, NA-IMPT plans are less sensitive to weight variations than one may expect. Still, we would advise to calculate new plans in case of substantial change in weight for patients treated in the sacral region, primarily due to the presence of new hot/cold area.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18199516     DOI: 10.1016/j.radonc.2007.11.032

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  15 in total

1.  Robust optimization for intensity-modulated proton therapy with soft spot sensitivity regularization.

Authors:  Wenbo Gu; Dan Ruan; Daniel O'Connor; Wei Zou; Lei Dong; Min-Yu Tsai; Xun Jia; Ke Sheng
Journal:  Med Phys       Date:  2019-01-21       Impact factor: 4.071

Review 2.  Myths and realities of range uncertainty.

Authors:  Antony John Lomax
Journal:  Br J Radiol       Date:  2019-12-23       Impact factor: 3.039

3.  Proton stereotactic body radiation therapy for clinically challenging cases of centrally and superiorly located stage I non-small-cell lung cancer.

Authors:  Steven P Register; Xiaodong Zhang; Radhe Mohan; Joe Y Chang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-07-07       Impact factor: 7.038

4.  Robust optimization in intensity-modulated proton therapy to account for anatomy changes in lung cancer patients.

Authors:  Heng Li; Xiaodong Zhang; Peter Park; Wei Liu; Joe Chang; Zhongxing Liao; Steve Frank; Yupeng Li; Falk Poenisch; Radhe Mohan; Michael Gillin; Ronald Zhu
Journal:  Radiother Oncol       Date:  2015-02-20       Impact factor: 6.280

5.  Bone marrow sparing in intensity modulated proton therapy for cervical cancer: Efficacy and robustness under range and setup uncertainties.

Authors:  Eric Dinges; Nicole Felderman; Sarah McGuire; Brandie Gross; Sudershan Bhatia; Sarah Mott; John Buatti; Dongxu Wang
Journal:  Radiother Oncol       Date:  2015-05-13       Impact factor: 6.280

Review 6.  Advanced radiation techniques for locally advanced non-small cell lung cancer: intensity-modulated radiation therapy and proton therapy.

Authors:  Nikhil Yegya-Raman; Wei Zou; Ke Nie; Jyoti Malhotra; Salma K Jabbour
Journal:  J Thorac Dis       Date:  2018-08       Impact factor: 2.895

7.  Synthetic CT-aided multiorgan segmentation for CBCT-guided adaptive pancreatic radiotherapy.

Authors:  Xianjin Dai; Yang Lei; Jacob Wynne; James Janopaul-Naylor; Tonghe Wang; Justin Roper; Walter J Curran; Tian Liu; Pretesh Patel; Xiaofeng Yang
Journal:  Med Phys       Date:  2021-10-13       Impact factor: 4.071

Review 8.  Proton radiobiology.

Authors:  Francesco Tommasino; Marco Durante
Journal:  Cancers (Basel)       Date:  2015-02-12       Impact factor: 6.639

9.  Systematic evaluation of three different commercial software solutions for automatic segmentation for adaptive therapy in head-and-neck, prostate and pleural cancer.

Authors:  Mariangela La Macchia; Francesco Fellin; Maurizio Amichetti; Marco Cianchetti; Stefano Gianolini; Vitali Paola; Antony J Lomax; Lamberto Widesott
Journal:  Radiat Oncol       Date:  2012-09-18       Impact factor: 3.481

Review 10.  Roadmap: proton therapy physics and biology.

Authors:  Harald Paganetti; Chris Beltran; Stefan Both; Lei Dong; Jacob Flanz; Keith Furutani; Clemens Grassberger; David R Grosshans; Antje-Christin Knopf; Johannes A Langendijk; Hakan Nystrom; Katia Parodi; Bas W Raaymakers; Christian Richter; Gabriel O Sawakuchi; Marco Schippers; Simona F Shaitelman; B K Kevin Teo; Jan Unkelbach; Patrick Wohlfahrt; Tony Lomax
Journal:  Phys Med Biol       Date:  2021-02-26       Impact factor: 4.174

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.